Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zeptometrix LLC has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is being reviewed by 1 distinct examiner, which reflects a narrow scope of current interaction with the USPTO. The prosecution is localized within 1 distinct art unit, ensuring that the technical evaluation is handled by a specific group of subject matter experts. This focused approach can lead to a more direct resolution of the pending application.
GRIZER, CASSANDRA SENN is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. Because this single action constitutes the total workload of 1 pending office action for the company, this examiner's decisions are central to the immediate success of the company's patent filings. This structure allows for a direct and focused engagement with the examiner to resolve any outstanding issues in the application. The company can prioritize its resources to meet the specific expectations of this examiner and the associated art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRIZER, CASSANDRA SENN | 1 | 75.0% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18344693 | CONTROL FOR PROTEIN-BASED ASSAY | GRIZER, CASSANDRA SENN | 2d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18344693 | CONTROL FOR PROTEIN-BASED ASSAY | GRIZER, CASSANDRA SENN | 2d overdue |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18344693 | CONTROL FOR PROTEIN-BASED ASSAY | GRIZER, CASSANDRA SENN | 1672 | §102§103§112 | Final Rejection | 2d overdue | Pending | Jun 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial